top of page

News

螢幕擷取畫面 2024-03-04 151613.png

2024.03.04
[Discovery New Taiwan] Asclepiumm Co., Ltd.

NewTV.260

2023.11.22
Ophthalmology New Drug Development Innovation Island! Taking Stock of Multiple Therapies' Phase II and III Data from 8 Taiwanese Companies

Global Bio & Investment Monthly

2023.11.09
Seeing the suffering of disease - Dr. Min-Che Chen founded 'Asclepiumm Taiwan Co., Ltd. to save incurable patients"

Moneyweekly

2022.06.07
The era of great supervision is coming! Peptide drugs open up affordable new drug treatment vision and business opportunities

Commercial Times

NEWS5

2021.06.21
Asclepiumm Chen Min-Che has been sharpening his sword for 10 years and bravely entered the blue ocean of new peptide drugs

Global Bio & Investment Monthly

NEWS4

2020.10.21
New drug development strives for early authorization!? An analysis of the strategies of four companies

Global Bio & Investment Monthly

NEWS3

2019.11.19
Taiwan Biotechnology Association leads a delegation to participate in BIO Europe to help Taiwanese biotechnology companies explore the European market

Global Bio & Investment Monthly

2019.11.11
Yang Muh-Hwa identified the key LTβ as a new target for drug resistance

Global Bio & Investment Monthly

2017.03.22
Interview: Chen Min-Che – Founder & Managing Director, Asclepiumm, Taiwan

Pharmaboardroom

bottom of page